• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Coral

    Cemdisiran Shows Deep Disease Control in gMG Phase 3 Trial

    PRESS RELEASE

    Pozelimab+Cemdisiran Superior to Ravulizumab in Hemoglobinuria

    GLOBENEWSWIRE

    Alnylam closes in on phase 3 launch for Regeneron-partnered med

    FIERCEBIOTECH

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.